Fidelity Advisor Series VII: Fidelity Advisor Healthcare Fund Class A
Fidelity Advisor Series VII: Fidelity Advisor Healthcare Fund Class A (FACDX)
This fund aims to achieve long-term capital growth for its investors. It primarily allocates its capital to equity securities. A substantial portion, at least 80%, of the portfolio is dedicated to firms whose core business revolves around the design, manufacturing, or sale of products and services within the healthcare and medical fields. The fund invests in companies operating both domestically and internationally. Its investment choices are guided by a thorough fundamental analysis, scrutinizing factors such as each company's financial stability, its competitive position in the industry, and the broader economic and market environment.
FACDX Mutual Fund Chart & Stats
- Previous Close
- $68.30
- Sub-Category
- Sector-Specific
- Total Liabilities
- $94.74M
- Last Dividend Ex-Date
- Dec 26, 2025
- Expense Ratio
- 0.96%
- Holding Count
- 101
- Brand
- Fidelity Advisor Series Vii
- Dividend Yield
- (10.93%)
- Category
- Equity
- Total Assets
- 3.21B
- Shares Outstanding
- N/A
- 52-Week Range
- $50.75 - $74.09
FACDX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 7.66% |
| DHRDanaher Corporation | 6.75% |
| TMOThermo Fisher Scientific | 6.31% |
| UNHUnitedhealth Group Inc. | 4.17% |
| JNJJohnson & Johnson | 3.78% |
| ABBVAbbvie | 3.62% |
| USD_CASHFidelity Revere Street Trust | 2.54% |
| ARGXArgenx | 2.09% |
| MRKMerck & Company | 2.09% |
| WSTWest Pharmaceutical Services, Inc. | 2.06% |
| Total | 41.07% |
Recently Viewed
No data currently available






